CSF neurogranin or tau distinguish typical and atypical Alzheimer disease

OBJECTIVE: To assess whether high levels of cerebrospinal fluid neurogranin are found in atypical as well as typical Alzheimer's disease. METHODS: Immunoassays were used to measure cerebrospinal fluid neurogranin in 114 participants including healthy controls (n = 27), biomarker‐proven amnestic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wellington, Henrietta, Paterson, Ross W., Suárez‐González, Aida, Poole, Teresa, Frost, Chris, Sjöbom, Ulrika, Slattery, Catherine F., Magdalinou, Nadia K., Lehmann, Manja, Portelius, Eric, Fox, Nick C., Blennow, Kaj, Zetterberg, Henrik, Schott, Jonathan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817822/
https://www.ncbi.nlm.nih.gov/pubmed/29468177
http://dx.doi.org/10.1002/acn3.518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817822/
https://www.ncbi.nlm.nih.gov/pubmed/29468177
http://dx.doi.org/10.1002/acn3.518

Ejemplares similares